Charles A. Stanley MD, Founder of the Congenital Hyperinsulinism Center at CHoP, joins AmideBio’s Scientific Advisory Board

Charles A. Stanley MD joins AmideBio’s scientific advisory board to help further the Company’s soluble glucagon program for treating hyperinsulinism (HI). Dr. Stanley is a world-renowned expert on disorders of insulin regulation in children and founded the Congenital Hyperinsulinism Center at the Children’s Hospital of Philadelphia (CHoP). He helped define the various types of HI and has pioneered best practices for the diagnosis and treatment of congenital HI.